Episode Details

🧠 Episode Summary

The new 2024 McDonald Criteria for diagnosing multiple sclerosis (MS) mark an important milestone: doctors can now confirm MS earlier and with greater confidence, allowing treatment to start sooner and potentially improving long-term outcomes.

In this episode, we explore what has changed since the 2017 version, why these updates matter, and how they affect people living with — or at risk of — MS.

📋 Key Points Covered

• What the McDonald Criteria are and why they matter

• The biggest updates in 2024 – including the role of CSF (oligoclonal bands)

• How Radiologically Isolated Syndrome (RIS) may now count as MS in some cases

• Why early diagnosis can make a real difference in the course of the disease

• When people with CIS or RIS should consider speaking with their neurologist again

🔍 For Listeners Living With MS or Early Symptoms

If you've previously been told you have a Clinically Isolated Syndrome (CIS) or Radiologically Isolated Syndrome (RIS), it may be worth revisiting your diagnosis.
The new criteria might change your status — and early treatment could help protect your long-term health.
Always discuss any concerns or new information with your neurologist.

💻 Read the Full Blog Article

You can find a detailed written version of this episode, including background information and visual explanations, here:
👉 Read the full article on MS-Perspektive.de: https://ms-perspektive.de/en/139-2024-mcdonald-criteria

📚 Scientific Reference

Based on:
International Panel on the Diagnosis of Multiple Sclerosis (2024).
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria.
Published in The Lancet Neurology,